Celsion Corp (NASDAQ:CLSN)

CAPS Rating: 1 out of 5

A biotechnology company dedicated to furthering the development and commercialization of treatment systems for cancer and other diseases using focused heat energy in combination with other therapeutic devices or heat-activated genes.

Recs

0
Player Avatar mdriver78 (49.86) Submitted: 3/6/2013 12:53:52 PM : Outperform Start Price: $0.00 CLSN Score: 0

Sell of seems overdone.

Featured Broker Partners


Advertisement